InMode Ltd.

NasdaqGS:INMD 주식 리포트

시가총액: US$885.1m

InMode 향후 성장

Future 기준 점검 0/6

InMode 의 수익은 연간 0.6% 감소할 것으로 예상되는 반면, 연간 수익은 1.5% 로 증가할 것으로 예상됩니다. EPS는 연간 0.3% 만큼 성장할 것으로 예상됩니다.

핵심 정보

-0.6%

이익 성장률

0.28%

EPS 성장률

Medical Equipment 이익 성장16.1%
매출 성장률1.5%
향후 자기자본이익률n/a
애널리스트 커버리지

Good

마지막 업데이트08 May 2026

최근 향후 성장 업데이트

Recent updates

내러티브 업데이트 • May 03

INMD: Buyback Plan And 2026 Guidance Will Support A Measured Outlook

Analysts kept their $15.00 price target for InMode unchanged, noting only minor shifts in inputs such as discount rate, revenue growth, profit margin, and future P/E assumptions as the basis for maintaining their view. What's in the News InMode issued revenue guidance for the first quarter of 2026, with expected revenue in a range of $81.5 million to $81.7 million, and reiterated its full year 2026 revenue outlook of $365 million to $375 million (Corporate Guidance).
내러티브 업데이트 • Apr 19

INMD: Takeover Talks And Buyback Plan Will Shape A Measured Outlook

InMode's updated analyst price target remains at $15.00, with analysts pointing to small shifts in the discount rate, revenue growth assumptions, profit margin, and future P/E as the key drivers behind the reaffirmed valuation view. What's in the News Media report that InMode is in talks to be sold for about US$1.1b to a foreign investment fund, pointing to ongoing interest from financial buyers (Calcalist).
내러티브 업데이트 • Apr 03

INMD: Potential Takeover Talks And Buyback Plan Will Shape A Balanced Outlook

Analysts have maintained their $15.00 price target for InMode, citing small adjustments to assumptions such as the discount rate, revenue growth, profit margin, and future P/E that did not materially affect their overall valuation view. What's in the News Media reports indicate InMode is in talks to be sold for about US$1.1b to a foreign investment fund, highlighting ongoing interest from financial buyers (Calcalist).
내러티브 업데이트 • Mar 20

INMD: Potential Sale Talks And Buyback Plan Will Shape A Measured Outlook

Analysts have kept their $15.00 price target on InMode unchanged, citing only very small tweaks to model inputs around discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major shift in their view of the stock. What's in the News Media report that InMode is in talks to be sold for about US$1.1 billion to a foreign investment fund, according to Calcalist (Calcalist).
내러티브 업데이트 • Mar 05

INMD: Potential Sale And Earnings Guidance Will Shape A Measured Forward View

Analysts have kept their $15.00 price target on InMode unchanged, citing only marginal tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E that did not materially alter their overall view of the stock. What's in the News Calcalist reports that InMode is in talks to be sold for about US$1.1b to a foreign investment fund, indicating ongoing interest in potential ownership changes (Calcalist).
내러티브 업데이트 • Feb 19

INMD: Potential Sale Talks And Earnings Guidance Will Shape A Balanced Outlook

Analysts kept their $15.00 price target for InMode steady, citing only slight adjustments in assumptions such as discount rate, revenue growth, profit margin, and future P/E as reasons for maintaining their view rather than making a material change. What's in the News Media report that InMode is in talks to be sold for about US$1.1b to a foreign investment fund, according to Calcalist (Periodical).
Seeking Alpha • Feb 18

InMode: Some Green Shoots Appearing, But The Market Hasn't Noticed

Summary InMode Ltd. remains a Strong Buy at current levels, supported by a robust balance sheet, proprietary technology, and international growth. Green shoots include a 2.7% rise in consumables/servicing revenue and 14.5% international sales growth, offsetting possible U.S. market saturation. Management guides for flat 2026 revenue, with new product launches and expanding international footprint positioning INMD for future upside. Despite management frustrations and takeover rumors, INMD's very low valuation and strong cash position offer compelling risk-reward for recovery-focused investors. Read the full article on Seeking Alpha
내러티브 업데이트 • Feb 04

INMD: Potential Sale Talks And Guidance Will Sustain A Cautious Fair Value View

Analysts have kept their price target for InMode steady at US$15.00, with only minor model tweaks to the discount rate, revenue growth, profit margin and assumed future P/E feeding into this unchanged view. What's in the News Media report that InMode is in talks to be sold to a foreign investment fund in a transaction valued at about US$1.1 billion, indicating active interest in the company from financial buyers (Periodical, Calcalist).
내러티브 업데이트 • Jan 21

INMD: Refreshed Guidance And Margin Outlook Will Support A Cautious Fair Value Stance

Analysts now see InMode's fair value holding at $15.00. The refreshed price target framework mainly reflects adjusted assumptions around discount rate, revenue growth, profit margin and future P/E rather than a change in the headline valuation level.
분석 기사 • Jan 07

InMode (NASDAQ:INMD) Could Be Struggling To Allocate Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
내러티브 업데이트 • Jan 06

INMD: Reaffirmed 2025 Revenue Guidance Will Underpin A Cautious Fairly Valued Outlook

Analysts have nudged their price target on InMode slightly higher to US$15.00 from US$15.00. This reflects small tweaks to assumptions on discount rate, revenue growth, profit margin, and future P/E that, in their view, modestly refine rather than overhaul the prior outlook.
내러티브 업데이트 • Dec 13

INMD: Revenue Outlook And Legal Overhang Will Shape A Cautious 2025 Outlook

Analysts have raised their price target on InMode by 1.00 dollar, reflecting improved expectations for a return to modest top line growth and slightly higher long term profitability multiples. What's in the News InMode reaffirmed its full year 2025 revenue outlook, maintaining guidance at $365 million to $375 million.
분석 기사 • Nov 12

There Might Be More To InMode's (NASDAQ:INMD) Story Than Just Weak Earnings

Shareholders didn't appear too concerned by InMode Ltd.'s ( NASDAQ:INMD ) weak earnings. We did some digging, and we...
분석 기사 • Jul 31

Should You Think About Buying InMode Ltd. (NASDAQ:INMD) Now?

InMode Ltd. ( NASDAQ:INMD ), might not be a large cap stock, but it saw significant share price movement during recent...
분석 기사 • Jun 30

An Intrinsic Calculation For InMode Ltd. (NASDAQ:INMD) Suggests It's 36% Undervalued

Key Insights InMode's estimated fair value is US$22.05 based on 2 Stage Free Cash Flow to Equity InMode's US$14.19...
분석 기사 • May 21

InMode (NASDAQ:INMD) Might Be Having Difficulty Using Its Capital Effectively

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Seeking Alpha • Apr 29

InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade)

Summary InMode's Q1 2025 earnings reveal a 3% YoY revenue decline and margin compression, signaling continued macroeconomic pressures and underutilization of installed platforms. Management's revised 2025 guidance lowers profitability expectations, reflecting ongoing challenges in the U.S. market and less profitable international expansion. Despite a strong balance sheet, past strategic missteps and ineffective cash allocation raise concerns about future shareholder value and growth prospects. Given the revenue declines and strategic uncertainties, I downgrade InMode to Hold, recommending caution until significant positive developments occur. Read the full article on Seeking Alpha
분석 기사 • Apr 26

Is Now The Time To Look At Buying InMode Ltd. (NASDAQ:INMD)?

While InMode Ltd. ( NASDAQ:INMD ) might not have the largest market cap around , it saw a decent share price growth of...
분석 기사 • Apr 11

Investors Don't See Light At End Of InMode Ltd.'s (NASDAQ:INMD) Tunnel And Push Stock Down 25%

InMode Ltd. ( NASDAQ:INMD ) shares have had a horrible month, losing 25% after a relatively good period beforehand...
Seeking Alpha • Feb 10

InMode: Plastic Surgery Boom, Cash Flow, And Cheap

Summary InMode is significantly undervalued, with strong cash flow, international expansion, and investments in research and marketing driving future revenue and free cash flow growth. The company benefits from the booming non-invasive plastic surgery market, expected to grow at a 14% CAGR from 2023 to 2030. INMD's stock repurchase program and substantial investments in bonds and bank deposits are expected to boost stock price and financial stability. Despite lower 2024 revenue, new product launches and international efforts indicate promising growth potential from 2025 to 2031. Read the full article on Seeking Alpha
Seeking Alpha • Jan 28

InMode: A Clear Bargain With Unique Risks

Summary InMode Ltd. boasts superior fundamentals, yet trades at undervalued market multiples due to its unique risk profile. The company is a leader in the global aesthetics market with proprietary RF-based technologies. InMode's robust balance sheet and high profit margins support a substantial margin of safety at current prices, despite risks. Read the full article on Seeking Alpha
분석 기사 • Jan 08

An Intrinsic Calculation For InMode Ltd. (NASDAQ:INMD) Suggests It's 50% Undervalued

Key Insights InMode's estimated fair value is US$34.79 based on 2 Stage Free Cash Flow to Equity Current share price of...
Seeking Alpha • Dec 12

InMode: Product Origination And Undervaluation Make The Stock A Buy

Summary InMode Ltd. demonstrates impressive net income growth from non-invasive surgical products, with new platforms Define and Envision expected to drive future business growth. The company's innovative technologies in plastic surgery, dermatology, gynecology, and ophthalmology, along with ongoing stock repurchases, make InMode a compelling buy. Strong financials show consistent income growth and significant cash flow, with minimal liabilities, indicating a robust financial position and undervaluation. Expansion into new markets, enhanced sales force, and continuous R&D in new treatment areas promise sustained revenue and free cash flow growth. Read the full article on Seeking Alpha
Seeking Alpha • Nov 05

InMode: $25/Share Is Closer Than You Think

Summary Elevated interest rates continue to hurt InMode’s revenue, especially as lease package interest rates haven't fallen yet. Still, future rate cuts could release pent-up demand. InMode continues to buy back shares at a low price, which will boost per-share results. InMode's manufacturing is done in Israel, presenting a risk, but the company has been managing this well despite the war. The stock is undervalued, with only modest FCF/share growth needed to achieve a $25 fair value. And this FCF/share growth can be supported by more buybacks. Organizational shifts don't have me worried at the moment, but they are worth monitoring because they present uncertainty. Read the full article on Seeking Alpha
분석 기사 • Nov 01

InMode Ltd. Just Recorded A 17% EPS Beat: Here's What Analysts Are Forecasting Next

InMode Ltd. ( NASDAQ:INMD ) investors will be delighted, with the company turning in some strong numbers with its...
분석 기사 • Sep 24

InMode (NASDAQ:INMD) Could Be Struggling To Allocate Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
User avatar
새로운 내러티브 • Sep 24

Innovations And Global Expansion Poised To Propel Medical Tech Leader To New Heights

Introduction of IgniteRF and Optimus Max platforms, alongside FDA clearance for Morpheus8, drives revenue growth through market penetration and expanding patient base.
Seeking Alpha • Sep 19

InMode Offers High Risk-Reward Opportunity Amid New Products And Rate Cuts (Rating Upgrade)

Summary InMode’s Q2 2024 revenue dropped by 36.5% year-over-year to $86.4 million, underlining macroeconomic challenges. The company revised its full-year 2024 revenue guidance to $430-$440 million due to slower platform rollouts and production delays. Lower interest rates from Federal Reserve cuts could boost demand for InMode's minimally invasive treatments, benefiting from reduced financing costs. New platforms IgniteRF and OptimasMAX are expected to drive future growth, appealing to clinics seeking cost-effective solutions. Despite short-term revenue declines, InMode’s attractive valuation and new growth catalysts position it as a "buy" opportunity. Read the full article on Seeking Alpha
Seeking Alpha • Sep 06

InMode Stock: An Inverse Bubble Caused By Short-Term Trouble

Summary InMode stock has significant upside potential due to its low valuation, profitability, share buybacks, and potential benefits from expected interest rate cuts. INMD's business model involves selling high-quality, expensive medical devices for aesthetic procedures, heavily influenced by interest rates due to customer financing. The stock's decline was driven by underutilized buybacks, declining revenue, and high interest rates, but recent buybacks and potential rate cuts offer a brighter outlook. Despite geopolitical risks, InMode's strong cash position, profitability, and the growing aesthetics market make it a long-term investment opportunity. Read the full article on Seeking Alpha
Seeking Alpha • Aug 12

InMode: Still Undervalued, But Short-Term Risks Warrant Caution (Rating Downgrade)

Summary Despite INMD being down -22% since I recommended to Buy the stock in March, InMode Ltd. remains a highly profitable & innovative leader in the aesthetic industry. Stronger than expected macroeconomic pressures and the slow but continuing escalation of the conflict in the Middle-East keep pushing the stock lower. Although I believe INMD remains significantly undervalued, the unpredictable situation in Israel as well as a probable FY2024 guidance miss are key risks that warrant caution. I am therefore downgrading INMD to Hold. I remain long for the mid-term upside potential, but I don’t expect upside catalysts before 2025. Read the full article on Seeking Alpha
분석 기사 • Aug 04

Here's What Analysts Are Forecasting For InMode Ltd. (NASDAQ:INMD) Following Its Earnings Miss

InMode Ltd. ( NASDAQ:INMD ) missed earnings with its latest second-quarter results, disappointing overly-optimistic...
Seeking Alpha • Jun 13

InMode: Reversing Previous Shareholder Dilution With Buybacks

Summary Shareholders of InMode Ltd. have seen a 46% decline in value due to slowing sales and capital allocation uncertainties. Sales growth has been impacted by rising interest rates affecting leasing deals, leading to lower revenue growth projections for 2024. The company's new share repurchase program should reverse the dilution shareholders previously experienced. The low expectations embedded into the company's valuation makes it ripe for a revision higher. Read the full article on Seeking Alpha
분석 기사 • May 29

Lacklustre Performance Is Driving InMode Ltd.'s (NASDAQ:INMD) Low P/E

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 18x, you may...
Seeking Alpha • May 08

InMode: Facing A Myraid Of Headwinds

Summary InMode's growth has plummeted due to sales execution issues, manufacturing delays, reduced demand, and high interest rates. INMD's business seems heavily reliant on economic conditions, beyond management's control. Shareholders expressed frustration with management's capital allocation decisions. I rate the company as a hold for now. Read the full article on Seeking Alpha
Seeking Alpha • Apr 27

InMode: More Headwinds Than Expected, Wait For A Floor To Materialize (Rating Downgrade)

Summary The market remains pessimistic about INMD's prospects, as observed in the stock's decline by -21.6% over the past three months, well underperforming the wider market at +4.7%. Part of the headwinds are attributed to the management's lowered FY2024 revenue guidance, building upon the FY2023 slowdown, as borrowing costs are still elevated for prospective buyers. Then again, we believe that consumer demand for skin-tightening devices and body contouring products may remain robust, thanks to the popularity of GLP-1 obesity therapies. The same has been observed in INMD's growing consumable sales, with it likely to drive intermediate-term growth as equipment sales temporarily stall. However, with the stock recording elevated short interest and the market experiencing an uncertain pullback, it may be more prudent to wait for a floor to materialize first. Read the full article on Seeking Alpha
Seeking Alpha • Apr 03

InMode's Quest For Growth Amidst Aesthetic Adversities

Summary InMode's Q4 revenue dropped YOY; management optimistic about new platforms despite industry challenges. High dependence on U.S. revenue from minimally invasive procedures; facing increasing competition in RF technology. R&D spending at 3% of revenue, below industry norm; sales and marketing costs rising. Investment stance: Hold, pending revenue diversification and increased R&D investment focus. Read the full article on Seeking Alpha
Seeking Alpha • Mar 26

InMode Does Not Look Pretty Right Now: Time To Buy

Summary Despite a highly profitable business model and a strong position in the medical aesthetics industry, INMD stock is down -33% over the last 12 months. Macroeconomic pressures, political risks in InMode’s home country Israel, and, to a lesser extent, suboptimal capital allocation have caused the stock to plummet. InMode continues to deliver cutting-edge innovation and expand its commercial capabilities, steadily gaining market share. Even without a share buyback program, INMD is grossly undervalued unless you believe the conflicts in Israel will escalate. With a fair value of $31 (range $25 to $39), it is time to buy INMD while most investors paint an ugly outlook for this aesthetics leader. Read the full article on Seeking Alpha
Seeking Alpha • Feb 16

InMode: Q4 Earnings Beat Not Enough - Macro Outlook Key To Buy Signal

Summary InMode beats revenue and EPS estimates in Q4 2023 earnings report. Q4 revenue is down 5% YoY and non-GAAP EPS is down 9% YoY. InMode maintains impressive gross margin of 84% and sees 20% YoY growth in revenue from consumables and services. Despite beating the lowered Q4 2023 expectations, InMode is facing challenging conditions with a weak 2024 outlook. Read the full article on Seeking Alpha

이익 및 매출 성장 예측

NasdaqGS:INMD - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)
날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수
12/31/20283898380824
12/31/20273797978796
12/31/20263707382836
3/31/2026375878687N/A
12/31/2025370948485N/A
9/30/20253641509495N/A
6/30/2025402179104105N/A
3/31/2025392176122123N/A
12/31/2024395181132133N/A
9/30/2024424154161161N/A
6/30/2024417149168169N/A
3/31/2024466181179180N/A
12/31/2023492198176177N/A
9/30/2023499180172173N/A
6/30/2023497183176177N/A
3/31/2023474171169171N/A
12/31/2022454162180182N/A
9/30/2022431176176177N/A
6/30/2022404172181182N/A
3/31/2022378169181182N/A
12/31/2021358165174175N/A
9/30/2021322148163164N/A
6/30/2021288128143143N/A
3/31/2021231959798N/A
12/31/2020206757979N/A
9/30/2020178586465N/A
6/30/2020158504848N/A
3/31/2020166576566N/A
12/31/201915661N/A62N/A
9/30/201913841N/A44N/A
6/30/201912434N/A38N/A
3/31/201911026N/A32N/A
12/31/201810022N/A37N/A
9/30/20189125N/A33N/A
6/30/20188019N/A30N/A
3/31/20186512N/A20N/A
12/31/2017538N/A15N/A
12/31/2016230N/A3N/A

애널리스트 향후 성장 전망

수입 대 저축률: INMD 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -0.6%).

수익 vs 시장: INMD 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -0.6%).

고성장 수익: INMD 의 수익은 향후 3년간 감소할 것으로 예상됩니다.

수익 대 시장: INMD 의 수익(연간 1.5%)이 US 시장(연간 11.6%)보다 느리게 성장할 것으로 예상됩니다.

고성장 매출: INMD 의 수익(연간 1.5%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: INMD의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.

성장 기업 찾아보기

7D

1Y

7D

1Y

7D

1Y

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/20 20:12
종가2026/05/20 00:00
수익2026/03/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

InMode Ltd.는 11명의 분석가가 다루고 있습니다. 이 중 6명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
null nullBaird
Jeffrey JohnsonBaird
Travis SteedBarclays